Left ventricular hypertrophy
Conditions
Interventions
Sponsors
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years and < 80 years, regardless of gender. 2.Capable of cooperating fully throughout the entire study and willing to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Primary cardiomyopathies, valvular heart diseases with a definitive diagnosis, intraventricular conduction disturbances, and arrhythmias (including frequent premature contractions, ventricular premature beats, atrial fibrillation, etc.). 2.A history of cardiovascular events, including myocardial infarction, stroke, prior coronary artery percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and hospitalizations for heart failure. 3.Emphysema. 4.BMI<18kg/m2; 5.Patients with thoracic deformities who are unable to undergo standard ECG testing. 6.Patients with cancer who are undergoing chemotherapy or radiotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Left Ventricular Mass Index(LVMI); | — |
Countries
China
Contacts
Public ContactYan Wang
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed